| Name | Morinidazole |
|---|---|
| Synonyms |
TUPWG40JAL
1-(2-Methyl-5-nitro-1H-imidazol-1-yl)-3-(4-morpholinyl)-2-propanol 4-Morpholineethanol, α-[(2-methyl-5-nitro-1H-imidazol-1-yl)methyl]- |
| Description | Morinidazole is a novel 5-nitroimidazole antimicrobial drug that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation, for the treatment of bacterial infections including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 521.4±50.0 °C at 760 mmHg |
| Molecular Formula | C11H18N4O4 |
| Molecular Weight | 270.285 |
| Flash Point | 269.2±30.1 °C |
| Exact Mass | 270.132813 |
| LogP | 0.46 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.632 |